A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Patients With Advanced Solid Tumors

NCT06963502 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

762

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors
Colorectal Cancer
Non-Small Cell Lung Cancer

Interventions

DRUG: HS-10370
DRUG: HS-20117
DRUG: Adebrelimab
DRUG: Capecitabine
DRUG: Oxaliplatin
DRUG: Folinic Acid, Fluorouracil and Oxaliplatin/Irinotecan
DRUG: HS-20093
DRUG: platinum (cisplatin or carboplatin)

Sponsor

Jiangsu Hansoh Pharmaceutical Co., Ltd.